Benjamin Uzan
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
-
- CAR-T cell therapy research
Papers in
-
- Receptor Mechanisms and Signaling 3
- Metabolism, Diabetes, and Cancer 2
-
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Hang‐Korng Ea (6 shared papers)Françoise Pflumio (13 shared papers)M. Cressent (3 shared papers)Frédéric Lioté (5 shared papers)Jamileh Movassat (6 shared papers)Bernard Portha (3 shared papers)Florence Figeac (3 shared papers)Julien Calvo (9 shared papers)
- Journals
- Blood Advances (3 papers)Biomedicine & Pharmacotherapy (2 papers)Leukemia (2 papers)Arthritis Research & Therapy (2 papers)Cell stem cell (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Benjamin Uzan
27 papers receiving 790 citations
Peers
Comparison fields: 5 of 75
- Hematology 113
- Oncology 183
- Immunology 120
- Radiation 52
- Cancer Research 75
Countries citing papers authored by Benjamin Uzan
This map shows the geographic impact of Benjamin Uzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Uzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Uzan more than expected).
Fields of papers citing papers by Benjamin Uzan
This network shows the impact of papers produced by Benjamin Uzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Uzan. The network helps show where Benjamin Uzan may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Uzan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 92 | |
| 2 | 2020 | 88 | |
| 3 | 2005 | 67 | |
| 4 | 2009 | 54 | |
| 5 | 2014 | 52 | |
| 6 | 2006 | 47 | |
| 7 | 2017 | 45 | |
| 8 | 2009 | 45 | |
| 9 | 2004 | 39 | |
| 10 | 2007 | 36 | |
| 11 | 2006 | 32 | |
| 12 | 2017 | 31 | |
| 13 | 2019 | 31 | |
| 14 | 2014 | 30 | |
| 15 | 2021 | 23 | |
| 16 | 2010 | 21 | |
| 17 | 2019 | 14 | |
| 18 | 2011 | 13 | |
| 19 | 2019 | 10 | |
| 20 | 2018 | 8 |
About Benjamin Uzan
Benjamin Uzan is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Immunology and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 793 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Neuropeptides and Animal Physiology (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Receptor Mechanisms and Signaling (3 papers), CAR-T cell therapy research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Hematology (113 citations), Oncology (183 citations), Immunology (120 citations), Radiation (52 citations) and Cancer Research (75 citations). Benjamin Uzan has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Hang‐Korng Ea, Françoise Pflumio, M. Cressent, Frédéric Lioté, Jamileh Movassat, Bernard Portha, Florence Figeac, Julien Calvo, Christian Rey and Jean‐Michel Garel. Their work appears in journals such as Blood Advances, Biomedicine & Pharmacotherapy, Leukemia, Arthritis Research & Therapy and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.